Work Package 1
We will look at how clinicians discuss patients’ treatment and care options with patients and their families to decide which recommendations to include in the ReSPECT plan. We will do this through observation of discussions between clinicians and patients and interviews with clinicians, patients, and families about their experience of the ReSPECT process to help us understand people’s experiences of the process and to help develop any improvements to it.
Clinicians taking part in the observations and interviews will be provided with an information sheet to explain the purpose of the study, inform them of their options, and seek their consent for participation.
Patients and relatives involved in the clinician observation will be asked by the clinician if they are happy for the researcher to be present and observe. Anyone in the room during the observation can ask for the researcher to leave if they are not happy with them being there.
Patients and relatives may be approached by a clinician to see if they are interested in taking part in an interview. Where a patient or relative expresses interest in participating, the researcher will then seek written informed consent prior to the interview and provide them with a participant information sheet.
Work Package 2
Anonymised audit data from the National Cardiac Arrest Audit Data (NCAA) will be transferred to the study team complying with NCAA's data sharing agreement terms and conditions. More information about NCAA is available here: https://www.icnarc.org/Our-Audit/Audits/Ncaa/About
Work Package 3
Information will be collected from medical notes of patients who are in hospital on certain days. These patients or relatives acting on behalf of the patient will be able to opt out of their medical notes being used in the study. Everyone affected will receive one of these leaflets explaining this part of the study and how to opt out. People can opt out until the data is analysed towards the end of the study. Information will be collected by hospital staff. Information will only include things that are relevant to the study like age, gender, and why the patient is in hospital. It will also include information from the ReSPECT record. Anything that could identify an individual will be removed by the hospital staff before the information is securely send to the university team who will analyse the information.
To find out more about how we will use Work Package 3 participant data, please see our data transparency statement for patients.
Work Package 4
Some Primary Care Practitioners working in the areas serving one of the six acute NHS hospitals taking part in WP1 and WP3 of the study will be invited to take part in focus groups. They will be provided with an information sheet to explain the purpose of the study, inform them of their options, and seek their consent for participation.
To find out more about how we will use Work Package 4 participant data, please see our data transparency statement for primary care practitioners.
The University of Warwick and University Hospitals Birmingham NHS Foundation Trust are the sponsors for this study based in the United Kingdom. We will be using information from participants in order to undertake this study and the University of Warwick will act as the data controller for this study. This means that we are responsible for looking after participants’ information and using it properly.
You can find out more about how we use your information in the following data transparency statements:
Work Package 1a - Clinicians, Implementers and Ward Managers
Work Package 1a - Patients and Relatives
Work Package 3 - Patients
Work Package 4 - Primary Care Practitioners
The University of Warwick Research Privacy Notice is also available to view here.
For general enquiries, please contact Claire Jacques (Trial Manager)